CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 19 enrolled
Drug / intervention
NEother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01443494
NCT01443494N/ACompleted
CompareCT.gov

High Mean Arterial Pressure Target Improves Microcirculation in Septic Shock Patients With Previous Hypertension

Southeast University, China·interventional·Posted Sep 29, 2011·Updated Jul 6, 2017

In Brief

A clinical study evaluating NE for Septic Shock. Completed, enrolled 19 participants across 1 site.

Detailed Summary

We hypothesized that the increase in MAP from 65 mmHg to patients' usual level improved sublingual microcirculation.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSeptic Shock
CountriesChina
Collaborators--

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedSep 29, 2011
Enrollment StartJun 1, 2011
Primary CompletionJun 1, 2012
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 14.8 years ago

Interventions

NEother

norepinephine